Risk of Periprosthetic Joint Infection in Patients With Ipsilateral Infected Arthroplasties
Background: The risk of periprosthetic joint infection (PJI) subsequently developing at a second site after an initial PJI has been documented to be approximately 18%-20%. To the best of our knowledge, only a single study has evaluated the incidence in ipsilateral joints and if the risk of infection...
Main Authors: | Robert M. Wetzel, MD, Giovanni A. Ayala, MD, Christopher W. Grayson, MD, Michael A. Miranda, DO, Peter Simon, PhD, Steven T. Lyons, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Arthroplasty Today |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352344124000086 |
Similar Items
-
What Are the Research Highlights of Periprosthetic Joint Infections From the 100 Most Cited Studies?
by: Marcos R. Gonzalez, MD, et al.
Published: (2024-12-01) -
The Economics of Revision Arthroplasty for Periprosthetic Joint Infection
by: Mackenzie A. Roof, MD, MBA, et al.
Published: (2023-10-01) -
Rapidly-growing mycobacterial infection: a recognized cause of early-onset prosthetic joint infection
by: Anupop Jitmuang, et al.
Published: (2017-12-01) -
Cefazolin Alone Versus Cefazolin With Tobramycin or Gentamicin as Intraoperative Antibiotic Prophylaxis for Total Joint Arthroplasty
by: Meera M. Dhodapkar, MD, MHS, et al.
Published: (2025-02-01) -
Similar periprosthetic joint infection rates after and before a national infection control program: a study of 45,438 primary total knee arthroplasties
by: Olof Thompson, et al.
Published: (2022-01-01)